InvestorsHub Logo
icon url

Rtime

06/28/20 12:31 PM

#88185 RE: Amatuer17 #88177

The only active clinical trial for BMS drug is scheduled for completion in 2015. The other two trials were closed out a few years ago.


Clinical Trial
NCT Number Sponsor Condition Start Date Phase
NCT03496662 Washington University School of Medicine|Bristol-Myers Squibb|Barnes-Jewish Hospital|National Institutes of Health (NIH)|National Cancer Institute (NCI)
Pancreatic Ductal Adenocarcinoma
August 31, 2018 Phase 1|Phase 2
NCT01049165 Bristol-Myers Squibb
Accelerated Intimal Hyperplasia
February 2010 Phase 1
NCT01752985 Bristol-Myers Squibb
Diabetic Kidney Disease
March 18, 2013 Phase 2